Antitumor Responses Stimulated by Dendritic Cells Are Improved by Triiodothyronine Binding to the Thyroid Hormone Receptor β
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2015-02-11 / Cancer Res. 2015 Apr;75(7):1265-74Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm
/in International Publications, Newcastle Disease Virus, Thyroid Cancer /von 2014-11-01 / J. Exp. Clin. Cancer Res. 2014 Nov;33:91Morphologic evidence of anti-tumor specificity of T cells activated by denritic cells derived from peripheral blood mononuclear cells of thyroid cancer patients
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2012-08-10 / Korean J. Physiol. Pharmacol. 2012 Aug;16(4):243-7Advances in cellular therapy for the treatment of thyroid cancer
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2010-06-29 / J Oncol 2010;2010:179491Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2009-07-01 / J. Intern. Med. 2009 Jul;266(1):99-113Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2009-06-01 / Oncol. Rep. 2009 Jun;21(6):1585-92Dendritic cell vaccination with xenogenic polypeptide hormone induces tumor rejection in neuroendocrine cancer
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2008-07-01 / Clin. Cancer Res. 2008 Jul;14(13):4298-305Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2008-02-01 / Horm. Metab. Res. 2008 Feb;40(2):108-16Results of a phase I clinical study using dendritic cell vaccinations for thyroid cancer
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2007-01-01 / Thyroid 2007 Jan;17(1):53-8IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de